Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

(2020) Victor M Corman et al.   Eurosurveillance

A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020

(2020) Ranawaka APM Perera et al.   Eurosurveillance

IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study

(2020) Andrea Padoan et al.   CLINICA CHIMICA ACTA

Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays

(2020) Niko Kohmer et al.   JOURNAL OF CLINICAL VIROLOGY

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies

(2020) Kathleen G. Beavis et al.   JOURNAL OF CLINICAL VIROLOGY

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

(2020) Lakshmanane Premkumar et al.   Science Immunology

Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1

(2018) Nehemya Friedman et al.   Viruses-Basel

BioVenn – a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams

(2008) Tim Hulsen et al.   BMC GENOMICS